IBDEI05X ; ; 01-AUG-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14347,1,2,0)
 ;;=2^12011
 ;;^UTILITY(U,$J,358.3,14347,1,3,0)
 ;;=3^Simple repair; 2.5 cm or less
 ;;^UTILITY(U,$J,358.3,14348,0)
 ;;=12013^^55^620^2^^^^1
 ;;^UTILITY(U,$J,358.3,14348,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14348,1,2,0)
 ;;=2^12013
 ;;^UTILITY(U,$J,358.3,14348,1,3,0)
 ;;=3^Simple repair; 2.6 cm to 5.0 cm
 ;;^UTILITY(U,$J,358.3,14349,0)
 ;;=12014^^55^620^3^^^^1
 ;;^UTILITY(U,$J,358.3,14349,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14349,1,2,0)
 ;;=2^12014
 ;;^UTILITY(U,$J,358.3,14349,1,3,0)
 ;;=3^Simple repair; 5.1 cm to 7.5 cm
 ;;^UTILITY(U,$J,358.3,14350,0)
 ;;=12015^^55^620^4^^^^1
 ;;^UTILITY(U,$J,358.3,14350,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14350,1,2,0)
 ;;=2^12015
 ;;^UTILITY(U,$J,358.3,14350,1,3,0)
 ;;=3^Simple repair; 7.6 cm to 12.5 cm
 ;;^UTILITY(U,$J,358.3,14351,0)
 ;;=12016^^55^620^5^^^^1
 ;;^UTILITY(U,$J,358.3,14351,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14351,1,2,0)
 ;;=2^12016
 ;;^UTILITY(U,$J,358.3,14351,1,3,0)
 ;;=3^Simple repair; 12.6 cm to 20 cm
 ;;^UTILITY(U,$J,358.3,14352,0)
 ;;=12017^^55^620^6^^^^1
 ;;^UTILITY(U,$J,358.3,14352,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14352,1,2,0)
 ;;=2^12017
 ;;^UTILITY(U,$J,358.3,14352,1,3,0)
 ;;=3^Simple repair; 20.1 cm to 30 cm
 ;;^UTILITY(U,$J,358.3,14353,0)
 ;;=12018^^55^620^7^^^^1
 ;;^UTILITY(U,$J,358.3,14353,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14353,1,2,0)
 ;;=2^12018
 ;;^UTILITY(U,$J,358.3,14353,1,3,0)
 ;;=3^Simple repair; over 30 cm
 ;;^UTILITY(U,$J,358.3,14354,0)
 ;;=90471^^55^621^1^^^^1
 ;;^UTILITY(U,$J,358.3,14354,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14354,1,2,0)
 ;;=2^90471
 ;;^UTILITY(U,$J,358.3,14354,1,3,0)
 ;;=3^Immunization Admin,1st Vaccine 
 ;;^UTILITY(U,$J,358.3,14355,0)
 ;;=90472^^55^621^2^^^^1
 ;;^UTILITY(U,$J,358.3,14355,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14355,1,2,0)
 ;;=2^90472
 ;;^UTILITY(U,$J,358.3,14355,1,3,0)
 ;;=3^Immunization Admin,Ea Addl Vacc
 ;;^UTILITY(U,$J,358.3,14356,0)
 ;;=99409^^55^622^2^^^^1
 ;;^UTILITY(U,$J,358.3,14356,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14356,1,2,0)
 ;;=2^99409
 ;;^UTILITY(U,$J,358.3,14356,1,3,0)
 ;;=3^Audit/DAS 15-30 min
 ;;^UTILITY(U,$J,358.3,14357,0)
 ;;=99408^^55^622^1^^^^1
 ;;^UTILITY(U,$J,358.3,14357,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14357,1,2,0)
 ;;=2^99408
 ;;^UTILITY(U,$J,358.3,14357,1,3,0)
 ;;=3^Alcohol/Subst Abuse Screen 15-30 min
 ;;^UTILITY(U,$J,358.3,14358,0)
 ;;=99406^^55^622^3^^^^1
 ;;^UTILITY(U,$J,358.3,14358,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14358,1,2,0)
 ;;=2^99406
 ;;^UTILITY(U,$J,358.3,14358,1,3,0)
 ;;=3^Behav Chng Smoking 3-10 min
 ;;^UTILITY(U,$J,358.3,14359,0)
 ;;=99407^^55^622^4^^^^1
 ;;^UTILITY(U,$J,358.3,14359,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14359,1,2,0)
 ;;=2^99407
 ;;^UTILITY(U,$J,358.3,14359,1,3,0)
 ;;=3^Behav Chng Smoking > 10 min
 ;;^UTILITY(U,$J,358.3,14360,0)
 ;;=99497^^55^623^1^^^^1
 ;;^UTILITY(U,$J,358.3,14360,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14360,1,2,0)
 ;;=2^99497
 ;;^UTILITY(U,$J,358.3,14360,1,3,0)
 ;;=3^Adv Care Plan w/ Pt/Fam by MD/QHP,1st 30 min
 ;;^UTILITY(U,$J,358.3,14361,0)
 ;;=99498^^55^623^2^^^^1
 ;;^UTILITY(U,$J,358.3,14361,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14361,1,2,0)
 ;;=2^99498
 ;;^UTILITY(U,$J,358.3,14361,1,3,0)
 ;;=3^Adv Care Plan w/ Pt/Fam by MD/QHP,Ea Addl 30 min
 ;;^UTILITY(U,$J,358.3,14362,0)
 ;;=99395^^55^624^1^^^^1
 ;;^UTILITY(U,$J,358.3,14362,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14362,1,2,0)
 ;;=2^99395
 ;;^UTILITY(U,$J,358.3,14362,1,3,0)
 ;;=3^Preventive Med,Est Pt,18-39
 ;;^UTILITY(U,$J,358.3,14363,0)
 ;;=99396^^55^624^2^^^^1
 ;;^UTILITY(U,$J,358.3,14363,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14363,1,2,0)
 ;;=2^99396
 ;;^UTILITY(U,$J,358.3,14363,1,3,0)
 ;;=3^Preventive Med,Est Pt,40-64
 ;;^UTILITY(U,$J,358.3,14364,0)
 ;;=99397^^55^624^3^^^^1
 ;;^UTILITY(U,$J,358.3,14364,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14364,1,2,0)
 ;;=2^99397
 ;;^UTILITY(U,$J,358.3,14364,1,3,0)
 ;;=3^Preventive Med,Est Pt > 64
 ;;^UTILITY(U,$J,358.3,14365,0)
 ;;=99385^^55^625^1^^^^1
 ;;^UTILITY(U,$J,358.3,14365,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14365,1,2,0)
 ;;=2^99385
 ;;^UTILITY(U,$J,358.3,14365,1,3,0)
 ;;=3^Preventive Med,New Pt,18-39
 ;;^UTILITY(U,$J,358.3,14366,0)
 ;;=99386^^55^625^2^^^^1
 ;;^UTILITY(U,$J,358.3,14366,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14366,1,2,0)
 ;;=2^99386
 ;;^UTILITY(U,$J,358.3,14366,1,3,0)
 ;;=3^Preventive Med,New Pt,40-64
 ;;^UTILITY(U,$J,358.3,14367,0)
 ;;=99387^^55^625^3^^^^1
 ;;^UTILITY(U,$J,358.3,14367,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14367,1,2,0)
 ;;=2^99387
 ;;^UTILITY(U,$J,358.3,14367,1,3,0)
 ;;=3^Preventive Med,New Pt > 64 
 ;;^UTILITY(U,$J,358.3,14368,0)
 ;;=99452^^55^626^1^^^^1
 ;;^UTILITY(U,$J,358.3,14368,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14368,1,2,0)
 ;;=2^99452
 ;;^UTILITY(U,$J,358.3,14368,1,3,0)
 ;;=3^E-Consult Results/Discussion with Patient
 ;;^UTILITY(U,$J,358.3,14369,0)
 ;;=Q0243^^55^627^3^^^^1
 ;;^UTILITY(U,$J,358.3,14369,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14369,1,2,0)
 ;;=2^Q0243
 ;;^UTILITY(U,$J,358.3,14369,1,3,0)
 ;;=3^Casirivimab & Imdevimab 2400mg           
 ;;^UTILITY(U,$J,358.3,14370,0)
 ;;=M0243^^55^627^4^^^^1
 ;;^UTILITY(U,$J,358.3,14370,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14370,1,2,0)
 ;;=2^M0243
 ;;^UTILITY(U,$J,358.3,14370,1,3,0)
 ;;=3^Casirivimab & Imdevimab Infusion         
 ;;^UTILITY(U,$J,358.3,14371,0)
 ;;=M0245^^55^627^1^^^^1
 ;;^UTILITY(U,$J,358.3,14371,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14371,1,2,0)
 ;;=2^M0245
 ;;^UTILITY(U,$J,358.3,14371,1,3,0)
 ;;=3^Bamlanivimab Infusion w/ Post Admin Monitoring
 ;;^UTILITY(U,$J,358.3,14372,0)
 ;;=Q0245^^55^627^2^^^^1
 ;;^UTILITY(U,$J,358.3,14372,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14372,1,2,0)
 ;;=2^Q0245
 ;;^UTILITY(U,$J,358.3,14372,1,3,0)
 ;;=3^Bamlanivivab 700mg
 ;;^UTILITY(U,$J,358.3,14373,0)
 ;;=99417^^55^628^1^^^^1
 ;;^UTILITY(U,$J,358.3,14373,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14373,1,2,0)
 ;;=2^99417
 ;;^UTILITY(U,$J,358.3,14373,1,3,0)
 ;;=3^Prolonged Svc,Ea 15min;Only w/ 99205 or 99215
 ;;^UTILITY(U,$J,358.3,14374,0)
 ;;=B18.2^^56^629^40
 ;;^UTILITY(U,$J,358.3,14374,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14374,1,3,0)
 ;;=3^Hepatitis C,Chr
 ;;^UTILITY(U,$J,358.3,14374,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,14374,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,14375,0)
 ;;=E11.9^^56^629^25
 ;;^UTILITY(U,$J,358.3,14375,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14375,1,3,0)
 ;;=3^Diabetes Type 2
 ;;^UTILITY(U,$J,358.3,14375,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,14375,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,14376,0)
 ;;=E11.40^^56^629^23
 ;;^UTILITY(U,$J,358.3,14376,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14376,1,3,0)
 ;;=3^DM Type 2 w/ Neuropathy
 ;;^UTILITY(U,$J,358.3,14376,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,14376,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,14377,0)
 ;;=E78.2^^56^629^41
 ;;^UTILITY(U,$J,358.3,14377,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14377,1,3,0)
 ;;=3^Hyperlipidemia,Mixed
 ;;^UTILITY(U,$J,358.3,14377,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,14377,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,14378,0)
 ;;=E78.5^^56^629^42
 ;;^UTILITY(U,$J,358.3,14378,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14378,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,14378,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,14378,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,14379,0)
 ;;=E66.3^^56^629^59
 ;;^UTILITY(U,$J,358.3,14379,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14379,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,14379,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,14379,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,14380,0)
 ;;=F17.200^^56^629^52
 ;;^UTILITY(U,$J,358.3,14380,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14380,1,3,0)
 ;;=3^Nicotine Dependence,Unspec
 ;;^UTILITY(U,$J,358.3,14380,1,4,0)
 ;;=4^F17.200
 ;;^UTILITY(U,$J,358.3,14380,2)
 ;;=^5003360
 ;;^UTILITY(U,$J,358.3,14381,0)
 ;;=G43.909^^56^629^50
 ;;^UTILITY(U,$J,358.3,14381,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14381,1,3,0)
 ;;=3^Migraine,Unspec
 ;;^UTILITY(U,$J,358.3,14381,1,4,0)
 ;;=4^G43.909
 ;;^UTILITY(U,$J,358.3,14381,2)
 ;;=^5003909
 ;;^UTILITY(U,$J,358.3,14382,0)
 ;;=H91.93^^56^629^36
 ;;^UTILITY(U,$J,358.3,14382,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14382,1,3,0)
 ;;=3^Hearing Loss,Bilateral
 ;;^UTILITY(U,$J,358.3,14382,1,4,0)
 ;;=4^H91.93
 ;;^UTILITY(U,$J,358.3,14382,2)
 ;;=^5006944
 ;;^UTILITY(U,$J,358.3,14383,0)
 ;;=I10.^^56^629^43
 ;;^UTILITY(U,$J,358.3,14383,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14383,1,3,0)
 ;;=3^Hypertension
 ;;^UTILITY(U,$J,358.3,14383,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,14383,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,14384,0)
 ;;=I50.9^^56^629^19
 ;;^UTILITY(U,$J,358.3,14384,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14384,1,3,0)
 ;;=3^Congestive Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,14384,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,14384,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,14385,0)
 ;;=I67.89^^56^629^18
 ;;^UTILITY(U,$J,358.3,14385,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14385,1,3,0)
 ;;=3^Cerebrovascular Disease,Oth
 ;;^UTILITY(U,$J,358.3,14385,1,4,0)
 ;;=4^I67.89
 ;;^UTILITY(U,$J,358.3,14385,2)
 ;;=^5007388
 ;;^UTILITY(U,$J,358.3,14386,0)
 ;;=J45.909^^56^629^4
 ;;^UTILITY(U,$J,358.3,14386,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14386,1,3,0)
 ;;=3^Asthma,Unspec,Uncomplicated
 ;;^UTILITY(U,$J,358.3,14386,1,4,0)
 ;;=4^J45.909
 ;;^UTILITY(U,$J,358.3,14386,2)
 ;;=^5008256
 ;;^UTILITY(U,$J,358.3,14387,0)
 ;;=J44.9^^56^629^16
 ;;^UTILITY(U,$J,358.3,14387,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14387,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,14387,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,14387,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,14388,0)
 ;;=K21.9^^56^629^31
 ;;^UTILITY(U,$J,358.3,14388,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14388,1,3,0)
 ;;=3^GERD w/o Esophagitis
 ;;^UTILITY(U,$J,358.3,14388,1,4,0)
 ;;=4^K21.9
 ;;^UTILITY(U,$J,358.3,14388,2)
 ;;=^5008505
 ;;^UTILITY(U,$J,358.3,14389,0)
 ;;=N40.1^^56^629^29
 ;;^UTILITY(U,$J,358.3,14389,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14389,1,3,0)
 ;;=3^Enlarged Prostate w/ LUTS
 ;;^UTILITY(U,$J,358.3,14389,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,14389,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,14390,0)
 ;;=L03.818^^56^629^17
 ;;^UTILITY(U,$J,358.3,14390,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14390,1,3,0)
 ;;=3^Cellulitis,Oth Sites
 ;;^UTILITY(U,$J,358.3,14390,1,4,0)
 ;;=4^L03.818
 ;;^UTILITY(U,$J,358.3,14390,2)
 ;;=^5009064
 ;;^UTILITY(U,$J,358.3,14391,0)
 ;;=G47.33^^56^629^77
 ;;^UTILITY(U,$J,358.3,14391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14391,1,3,0)
 ;;=3^Sleep Apnea,Obstructive
 ;;^UTILITY(U,$J,358.3,14391,1,4,0)
 ;;=4^G47.33
 ;;^UTILITY(U,$J,358.3,14391,2)
 ;;=^332763
 ;;^UTILITY(U,$J,358.3,14392,0)
 ;;=R73.01^^56^629^46
 ;;^UTILITY(U,$J,358.3,14392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14392,1,3,0)
 ;;=3^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,14392,1,4,0)
 ;;=4^R73.01
 ;;^UTILITY(U,$J,358.3,14392,2)
 ;;=^5019561
 ;;^UTILITY(U,$J,358.3,14393,0)
 ;;=R74.8^^56^629^1
 ;;^UTILITY(U,$J,358.3,14393,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14393,1,3,0)
 ;;=3^Abnormal Levels of Serum Enzymes
 ;;^UTILITY(U,$J,358.3,14393,1,4,0)
 ;;=4^R74.8
 ;;^UTILITY(U,$J,358.3,14393,2)
 ;;=^5019566
 ;;^UTILITY(U,$J,358.3,14394,0)
 ;;=R03.0^^56^629^27
 ;;^UTILITY(U,$J,358.3,14394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14394,1,3,0)
 ;;=3^Elevated BP Reading w/o Diagnosis of HTN
 ;;^UTILITY(U,$J,358.3,14394,1,4,0)
 ;;=4^R03.0
 ;;^UTILITY(U,$J,358.3,14394,2)
 ;;=^5019171
 ;;^UTILITY(U,$J,358.3,14395,0)
 ;;=Z91.19^^56^629^53
 ;;^UTILITY(U,$J,358.3,14395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14395,1,3,0)
 ;;=3^Noncompliance w/ Medical Treatment/Regimen
 ;;^UTILITY(U,$J,358.3,14395,1,4,0)
 ;;=4^Z91.19
 ;;^UTILITY(U,$J,358.3,14395,2)
 ;;=^5063618
 ;;^UTILITY(U,$J,358.3,14396,0)
 ;;=E66.01^^56^629^54
 ;;^UTILITY(U,$J,358.3,14396,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14396,1,3,0)
 ;;=3^Obesity,Morbid
 ;;^UTILITY(U,$J,358.3,14396,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,14396,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,14397,0)
 ;;=F43.11^^56^629^61
 ;;^UTILITY(U,$J,358.3,14397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14397,1,3,0)
 ;;=3^PTSD,Acute
 ;;^UTILITY(U,$J,358.3,14397,1,4,0)
 ;;=4^F43.11
 ;;^UTILITY(U,$J,358.3,14397,2)
 ;;=^5003571
 ;;^UTILITY(U,$J,358.3,14398,0)
 ;;=F43.12^^56^629^62
 ;;^UTILITY(U,$J,358.3,14398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14398,1,3,0)
 ;;=3^PTSD,Chronic
 ;;^UTILITY(U,$J,358.3,14398,1,4,0)
 ;;=4^F43.12
 ;;^UTILITY(U,$J,358.3,14398,2)
 ;;=^5003572
 ;;^UTILITY(U,$J,358.3,14399,0)
 ;;=I25.119^^56^629^5
 ;;^UTILITY(U,$J,358.3,14399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14399,1,3,0)
 ;;=3^Athscl Hrt Dis of Native Cor Art w/ Ang Pctrs,Unspec
 ;;^UTILITY(U,$J,358.3,14399,1,4,0)
 ;;=4^I25.119
 ;;^UTILITY(U,$J,358.3,14399,2)
 ;;=^5007111
 ;;^UTILITY(U,$J,358.3,14400,0)
 ;;=I25.10^^56^629^6
 ;;^UTILITY(U,$J,358.3,14400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14400,1,3,0)
 ;;=3^Athscl Hrt Dis of Native Cor Art w/o Ang Pctrs
 ;;^UTILITY(U,$J,358.3,14400,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,14400,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,14401,0)
 ;;=F17.219^^56^629^51
 ;;^UTILITY(U,$J,358.3,14401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14401,1,3,0)
 ;;=3^Nicotine Dependence,Cigarettes
 ;;^UTILITY(U,$J,358.3,14401,1,4,0)
 ;;=4^F17.219
 ;;^UTILITY(U,$J,358.3,14401,2)
 ;;=^5003369
 ;;^UTILITY(U,$J,358.3,14402,0)
 ;;=Z51.5^^56^629^64
 ;;^UTILITY(U,$J,358.3,14402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14402,1,3,0)
 ;;=3^Palliative Care Encounter
 ;;^UTILITY(U,$J,358.3,14402,1,4,0)
 ;;=4^Z51.5
 ;;^UTILITY(U,$J,358.3,14402,2)
 ;;=^5063063
 ;;^UTILITY(U,$J,358.3,14403,0)
 ;;=Z23.^^56^629^28
 ;;^UTILITY(U,$J,358.3,14403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14403,1,3,0)
 ;;=3^Encounter for Immunization(s)
 ;;^UTILITY(U,$J,358.3,14403,1,4,0)
 ;;=4^Z23.
 ;;^UTILITY(U,$J,358.3,14403,2)
 ;;=^5062795
 ;;^UTILITY(U,$J,358.3,14404,0)
 ;;=E11.65^^56^629^20
 ;;^UTILITY(U,$J,358.3,14404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14404,1,3,0)
 ;;=3^DM Type 2 Uncontrolled w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,14404,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,14404,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,14405,0)
 ;;=E11.649^^56^629^21
 ;;^UTILITY(U,$J,358.3,14405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14405,1,3,0)
 ;;=3^DM Type 2 Uncontrolled w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,14405,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,14405,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,14406,0)
 ;;=I16.0^^56^629^44
 ;;^UTILITY(U,$J,358.3,14406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14406,1,3,0)
 ;;=3^Hypertensive Urgency
 ;;^UTILITY(U,$J,358.3,14406,1,4,0)
 ;;=4^I16.0
 ;;^UTILITY(U,$J,358.3,14406,2)
 ;;=^8133013
 ;;^UTILITY(U,$J,358.3,14407,0)
 ;;=H54.8^^56^629^47
 ;;^UTILITY(U,$J,358.3,14407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14407,1,3,0)
 ;;=3^Legal Blindness,USA Definition
 ;;^UTILITY(U,$J,358.3,14407,1,4,0)
 ;;=4^H54.8
 ;;^UTILITY(U,$J,358.3,14407,2)
 ;;=^5006369
 ;;^UTILITY(U,$J,358.3,14408,0)
 ;;=F10.10^^56^629^2
 ;;^UTILITY(U,$J,358.3,14408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14408,1,3,0)
 ;;=3^Alcohol Abuse,Uncomplicated
 ;;^UTILITY(U,$J,358.3,14408,1,4,0)
 ;;=4^F10.10
 ;;^UTILITY(U,$J,358.3,14408,2)
 ;;=^5003068
 ;;^UTILITY(U,$J,358.3,14409,0)
 ;;=J30.9^^56^629^3
 ;;^UTILITY(U,$J,358.3,14409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14409,1,3,0)
 ;;=3^Allergic Rhinitis,Unspec
 ;;^UTILITY(U,$J,358.3,14409,1,4,0)
 ;;=4^J30.9
 ;;^UTILITY(U,$J,358.3,14409,2)
 ;;=^5008205
 ;;^UTILITY(U,$J,358.3,14410,0)
 ;;=I48.0^^56^629^7
 ;;^UTILITY(U,$J,358.3,14410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14410,1,3,0)
 ;;=3^Atrial Fibrillation Paroxysmal (PAF)
 ;;^UTILITY(U,$J,358.3,14410,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,14410,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,14411,0)
 ;;=N18.1^^56^629^9
 ;;^UTILITY(U,$J,358.3,14411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14411,1,3,0)
 ;;=3^CKD,Stage 1
 ;;^UTILITY(U,$J,358.3,14411,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,14411,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,14412,0)
 ;;=N18.2^^56^629^10
 ;;^UTILITY(U,$J,358.3,14412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14412,1,3,0)
 ;;=3^CKD,Stage 2
 ;;^UTILITY(U,$J,358.3,14412,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,14412,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,14413,0)
 ;;=N18.4^^56^629^14
 ;;^UTILITY(U,$J,358.3,14413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14413,1,3,0)
 ;;=3^CKD,Stage 4
 ;;^UTILITY(U,$J,358.3,14413,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,14413,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,14414,0)
 ;;=N18.5^^56^629^15
 ;;^UTILITY(U,$J,358.3,14414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14414,1,3,0)
 ;;=3^CKD,Stage 5
 ;;^UTILITY(U,$J,358.3,14414,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,14414,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,14415,0)
 ;;=N18.6^^56^629^26
 ;;^UTILITY(U,$J,358.3,14415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14415,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,14415,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,14415,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,14416,0)
 ;;=E11.22^^56^629^22
 ;;^UTILITY(U,$J,358.3,14416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14416,1,3,0)
 ;;=3^DM Type 2 w/ CKD
 ;;^UTILITY(U,$J,358.3,14416,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,14416,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,14417,0)
 ;;=E11.319^^56^629^24
 ;;^UTILITY(U,$J,358.3,14417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14417,1,3,0)
 ;;=3^DM Type 2 w/ Retinopathy Unspec w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,14417,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,14417,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,14418,0)
 ;;=G40.909^^56^629^76
 ;;^UTILITY(U,$J,358.3,14418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14418,1,3,0)
 ;;=3^Seizure Disorder NOS
 ;;^UTILITY(U,$J,358.3,14418,1,4,0)
 ;;=4^G40.909
 ;;^UTILITY(U,$J,358.3,14418,2)
 ;;=^5003865
 ;;^UTILITY(U,$J,358.3,14419,0)
 ;;=N52.9^^56^629^30
 ;;^UTILITY(U,$J,358.3,14419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14419,1,3,0)
 ;;=3^Erectile Dysfuntion,Unspec
 ;;^UTILITY(U,$J,358.3,14419,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,14419,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,14420,0)
 ;;=I50.22^^56^629^39
 ;;^UTILITY(U,$J,358.3,14420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14420,1,3,0)
 ;;=3^Heart Failure,Systolic,Chronic
 ;;^UTILITY(U,$J,358.3,14420,1,4,0)
 ;;=4^I50.22
 ;;^UTILITY(U,$J,358.3,14420,2)
 ;;=^5007241
 ;;^UTILITY(U,$J,358.3,14421,0)
 ;;=I50.32^^56^629^37
 ;;^UTILITY(U,$J,358.3,14421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14421,1,3,0)
 ;;=3^Heart Failure,Diastolic,Chronic
